Cited 0 time in
Feasibility of intraoperative intraperitoneal chemotherapy with paclitaxel in patients with epithelial ovarian cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, W. M. | - |
| dc.contributor.author | Choi, J. S. | - |
| dc.contributor.author | Bae, J. | - |
| dc.contributor.author | Eom, J. M. | - |
| dc.contributor.author | Jung, U. S. | - |
| dc.date.accessioned | 2021-09-27T06:18:04Z | - |
| dc.date.available | 2021-09-27T06:18:04Z | - |
| dc.date.created | 2021-09-23 | - |
| dc.date.issued | 2019-06 | - |
| dc.identifier.issn | 0090-8258 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/133097 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
| dc.title | Feasibility of intraoperative intraperitoneal chemotherapy with paclitaxel in patients with epithelial ovarian cancer | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Lee, W. M. | - |
| dc.contributor.affiliatedAuthor | Bae, J. | - |
| dc.identifier.wosid | 000581778900616 | - |
| dc.identifier.bibliographicCitation | GYNECOLOGIC ONCOLOGY, pp.274 | - |
| dc.relation.isPartOf | GYNECOLOGIC ONCOLOGY | - |
| dc.relation.isPartOf | GYNECOLOGIC ONCOLOGY | - |
| dc.citation.title | GYNECOLOGIC ONCOLOGY | - |
| dc.citation.startPage | 274 | - |
| dc.citation.endPage | 274 | - |
| dc.citation.conferencePlace | US | - |
| dc.citation.conferenceDate | 2019-06 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 1 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0090825819311369?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
